Effects of a Dietary Supplement Composed of Diosmin, Hesperidin, Bromelain, and Ruscus Aculeatus on the Quality of Life in Subjects With Lower Limb Disorders Possibly Prodromal to Chronic Venous Disease

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary objective of the study is to evaluate, after 12 weeks (visit 3, V3), the effect of the combination of diosmin, hesperidin, bromelain, and Ruscus aculeatus (Vesvein Gambe) on any changes in the total quality of life score, measured using the CIVIQ-20 (Chronic Venous Insufficiency Quality of Life Questionnaire), compared to baseline (visit 1, V1), in individuals with subjective symptoms in one or both lower limbs attributable to Chronic Venous Disease (CVD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Both sexes;

• Age ≥18 years;

• Signed informed consent form for participation in the study;

• Presence of at least one clinical symptom possibly related to chronic venous disease (such as heaviness and/or swelling and/or pain in the lower limbs, nighttime cramps, tired/heavy legs, itching, burning and/or warmth, tingling, or restlessness in the lower limbs);

• Willingness to participate in the study and to comply with the study procedures, as confirmed by signing the written informed consent.

Locations
Other Locations
Italy
Azienda ULSS7 Pademontana Regione Veneto
NOT_YET_RECRUITING
Bassano Del Grappa
AOU Policlinico Sant'Orsola Malpighi
NOT_YET_RECRUITING
Bologna
Università degli Studi Magna Graecia
NOT_YET_RECRUITING
Catanzaro
IRCCS San Raffaele Pisana
RECRUITING
Roma
Ospedale Policlinico Agostino Gemelli
NOT_YET_RECRUITING
Roma
Vi.Gi. Centro Polispecialistico
RECRUITING
Vibo Valentia
Contact Information
Primary
Francesco Salvo
francesco.salvo@ekalab.com
+390422633666
Time Frame
Start Date: 2025-05-28
Estimated Completion Date: 2027-01-31
Participants
Target number of participants: 84
Treatments
Experimental: VESVEIN
VESVEIN Gambe, (Ekalab S.r.l., Italia)
Related Therapeutic Areas
Sponsors
Leads: Ekalab S.r.l.

This content was sourced from clinicaltrials.gov